Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial.
Tomaschitz A, Verheyen N, Meinitzer A, Pieske B, Belyavskiy E, Brussee H, Haas J, März W, Pieske-Kraigher E, Verheyen S, Ofner-Ziegenfuss L, Hartaigh BÓ, Schwetz V, Aberer F, Grübler M, Lang F, Alesutan I, Voelkl J, Gaksch M, Horina JH, Dimai HP, Rus-Machan J, Stiegler C, Ritz E, Fahrleitner-Pammer A, Pilz S.
Tomaschitz A, et al.
J Hypertens. 2016 Jul;34(7):1347-56. doi: 10.1097/HJH.0000000000000927.
J Hypertens. 2016.
PMID: 27065001
Clinical Trial.